Uric acid - its role as a risk factor for the metabolic syndrome, cardiovascular and kidney disease

Uric acid as a potential risk factor for cardiovascular and renal conditions has gained renewed attention. In this work we aimed to assess the associations between serum uric acid, metabolic syndrome, hypertension, renal dysfunction, cardiovascular events and mortality. In paper I, 6083 participants...

Full description

Bibliographic Details
Main Author: Storhaug, Hilde
Format: Doctoral or Postdoctoral Thesis
Language:English
Published: UiT The Arctic University of Norway 2016
Subjects:
Online Access:https://hdl.handle.net/10037/11502
_version_ 1829300214573301760
author Storhaug, Hilde
author_facet Storhaug, Hilde
author_sort Storhaug, Hilde
collection University of Tromsø: Munin Open Research Archive
description Uric acid as a potential risk factor for cardiovascular and renal conditions has gained renewed attention. In this work we aimed to assess the associations between serum uric acid, metabolic syndrome, hypertension, renal dysfunction, cardiovascular events and mortality. In paper I, 6083 participants from Tromsø 4 were stratified according to body mass index. Endpoints were the metabolic syndrome and each component of the syndrome after seven years. Increased levels of baseline serum uric acid independently predicted development of hypertension and higher fasting glycemia in the overweight, but not in the normal-weight subjects. Baseline and longitudinal serum uric acid were both predictors of future metabolic syndrome. A prospective study that included 2637 participants who participated in Tromsø 4, 5 and 6 was described in paper II. We assessed the associations between change in serum uric acid during follow-up, baseline serum uric acid and renal dysfunction (defined as albumin-creatinine-ratio ≥1.13 mg albumin/mmol creatinine and/or estimated glomerular filtration rate < 60 ml/min/1.73 m2). Participants were stratified according to tertiles of change in serum uric acid between baseline and follow-up 13 years later. The upper tertile, compared to the two lower tertiles, had a doubled risk of renal dysfunction after 7 years, and after 13 years the odds ratio for renal dysfunction was 2.18. The risk of developing albumin-creatinine-ratio ≥1.13 mg/mmol alone was also significantly increased. An increase in baseline serum uric acid of 59 μmol/L gave an odds ratio of 1.16 for renal dysfunction after 13 years. In paper III, we included 5700 participants from Tromsø 4, and assessed the associations between serum uric acid and all-cause mortality after 15 years, and fatal or non-fatal myocardial infarction and ischemic stroke after 12 years. Serum uric acid was associated with all-cause mortality in men and women, even after adjustment for blood pressure, estimated glomerular filtration rate, urinary albumin ...
format Doctoral or Postdoctoral Thesis
genre Tromsø
genre_facet Tromsø
geographic Tromsø
geographic_facet Tromsø
id ftunivtroemsoe:oai:munin.uit.no:10037/11502
institution Open Polar
language English
op_collection_id ftunivtroemsoe
op_relation https://hdl.handle.net/10037/11502
op_rights Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)
openAccess
Copyright 2016 The Author(s)
https://creativecommons.org/licenses/by-nc-sa/3.0
publishDate 2016
publisher UiT The Arctic University of Norway
record_format openpolar
spelling ftunivtroemsoe:oai:munin.uit.no:10037/11502 2025-04-13T14:27:33+00:00 Uric acid - its role as a risk factor for the metabolic syndrome, cardiovascular and kidney disease Storhaug, Hilde 2016-12-06 https://hdl.handle.net/10037/11502 eng eng UiT The Arctic University of Norway UiT Norges arktiske universitet https://hdl.handle.net/10037/11502 Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0) openAccess Copyright 2016 The Author(s) https://creativecommons.org/licenses/by-nc-sa/3.0 VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Kardiologi: 771 VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Nefrologi urologi: 772 VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Hematologi: 775 VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Hematology: 775 VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Nephrology urology: 772 VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Cardiology: 771 The Tromsø Study Tromsøundersøkelsen Doctoral thesis Doktorgradsavhandling 2016 ftunivtroemsoe 2025-03-14T05:17:57Z Uric acid as a potential risk factor for cardiovascular and renal conditions has gained renewed attention. In this work we aimed to assess the associations between serum uric acid, metabolic syndrome, hypertension, renal dysfunction, cardiovascular events and mortality. In paper I, 6083 participants from Tromsø 4 were stratified according to body mass index. Endpoints were the metabolic syndrome and each component of the syndrome after seven years. Increased levels of baseline serum uric acid independently predicted development of hypertension and higher fasting glycemia in the overweight, but not in the normal-weight subjects. Baseline and longitudinal serum uric acid were both predictors of future metabolic syndrome. A prospective study that included 2637 participants who participated in Tromsø 4, 5 and 6 was described in paper II. We assessed the associations between change in serum uric acid during follow-up, baseline serum uric acid and renal dysfunction (defined as albumin-creatinine-ratio ≥1.13 mg albumin/mmol creatinine and/or estimated glomerular filtration rate < 60 ml/min/1.73 m2). Participants were stratified according to tertiles of change in serum uric acid between baseline and follow-up 13 years later. The upper tertile, compared to the two lower tertiles, had a doubled risk of renal dysfunction after 7 years, and after 13 years the odds ratio for renal dysfunction was 2.18. The risk of developing albumin-creatinine-ratio ≥1.13 mg/mmol alone was also significantly increased. An increase in baseline serum uric acid of 59 μmol/L gave an odds ratio of 1.16 for renal dysfunction after 13 years. In paper III, we included 5700 participants from Tromsø 4, and assessed the associations between serum uric acid and all-cause mortality after 15 years, and fatal or non-fatal myocardial infarction and ischemic stroke after 12 years. Serum uric acid was associated with all-cause mortality in men and women, even after adjustment for blood pressure, estimated glomerular filtration rate, urinary albumin ... Doctoral or Postdoctoral Thesis Tromsø University of Tromsø: Munin Open Research Archive Tromsø
spellingShingle VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Kardiologi: 771
VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Nefrologi
urologi: 772
VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Hematologi: 775
VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Hematology: 775
VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Nephrology
urology: 772
VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Cardiology: 771
The Tromsø Study
Tromsøundersøkelsen
Storhaug, Hilde
Uric acid - its role as a risk factor for the metabolic syndrome, cardiovascular and kidney disease
title Uric acid - its role as a risk factor for the metabolic syndrome, cardiovascular and kidney disease
title_full Uric acid - its role as a risk factor for the metabolic syndrome, cardiovascular and kidney disease
title_fullStr Uric acid - its role as a risk factor for the metabolic syndrome, cardiovascular and kidney disease
title_full_unstemmed Uric acid - its role as a risk factor for the metabolic syndrome, cardiovascular and kidney disease
title_short Uric acid - its role as a risk factor for the metabolic syndrome, cardiovascular and kidney disease
title_sort uric acid - its role as a risk factor for the metabolic syndrome, cardiovascular and kidney disease
topic VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Kardiologi: 771
VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Nefrologi
urologi: 772
VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Hematologi: 775
VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Hematology: 775
VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Nephrology
urology: 772
VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Cardiology: 771
The Tromsø Study
Tromsøundersøkelsen
topic_facet VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Kardiologi: 771
VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Nefrologi
urologi: 772
VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Hematologi: 775
VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Hematology: 775
VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Nephrology
urology: 772
VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Cardiology: 771
The Tromsø Study
Tromsøundersøkelsen
url https://hdl.handle.net/10037/11502